• Targets Eye Bags & Dark Circles – Peptide-rich formula revitalizes under-eye skin for a refreshed, youthful look.
• Reduces Crow’s Feet & Fine Lines – Smooths visible signs of aging around the eyes with advanced anti-aging peptides.
• Boosts Natural Collagen Production – Encourages long-term skin regeneration for firmer, radiant under-eye skin.
• Hydrating & Gradual-Release Formula – Deeply moisturizes with hyaluronic acid while delivering sustained improvements.
Revitalize and Rejuvenate Tired Eyes for a Radiant Look
Due to legal requirements, this product comes without needles.
Prostrolane Inner B SE reduces dark circles, eye bags, and crow's feet by revitalizing the skin around the eyes with a combination of hyaluronic acid and a four-part peptide complex. This advanced formula encourages natural collagen formation, resulting in a more awake and radiant appearance. Administered through application into the deep dermis, it offers lasting results with its delayed effect technology. For optimal outcomes, two treatment sessions spaced two weeks apart are recommended.
Aesthetic practitioners find Prostrolane Inner B SE beneficial for their patients seeking to diminish signs of aging around the eyes. With its innovative blend of peptides and hyaluronic acid, this product effectively addresses common concerns like sagging eye bags and dark circles. Its ability to promote natural collagen synthesis makes it an effective choice for enhancing the under-eye area in aesthetic clinics.
The comprehensive approach taken in evaluating Prostrolane Inner B SE reflects its effectiveness at reducing common aging issues around the eyes within aesthetic medicine practices.
Peptide-Powered Eye Rejuvenation with Lasting Results
This powerful applicable targets visible signs of aging around the eyes with a unique four-part peptide complex that includes sodium hyaluronate, nonapeptide-32, pentapeptide-43, tripeptide-41, and octapeptide-11. It helps reduce crow’s feet and rejuvenate tired under-eye skin for a fresh, radiant appearance.
The formula provides deep hydration and supports the body’s natural collagen production, resulting in smoother, firmer skin over time. With its gradual-release effect, improvements appear more slowly but last longer—offering sustained, natural-looking results.
Applied into the deep dermis using a 27 G x 13 mm or 30 G x 13 mm needle, subtle changes may be seen immediately after treatment. Full results typically develop around two weeks after the second session.
FAQs
What is Prostrolane Inner B SE?
Prostrolane Inner B SE is an applicable dermal filler made from a unique peptide complex and hyaluronic acid. It targets sagging eye bags, dark circles, and crow’s feet to revitalize the under-eye area.
What does a package of Prostrolane Inner B SE contain?
Each box contains one pre-filled syringe with 1 ml of product. Please note that, due to legal regulations, needles are not included and must be purchased separately.
The formulation includes active ingredients such as Sodium Hyaluronate, Nonapeptide-32, Pentapeptide-43, Tripeptide-41, and Octapeptide-11.
How should Prostrolane Inner B SE be applied?
Prostrolane Inner B SE must be applied into the deep dermis using a 27 G x 13 mm or 30 G x 13 mm needle. Superficial applications may cause visible lumps under the skin. This procedure should only be performed by trained medical professionals.
How soon will I see results after a Prostrolane Inner B SE treatment?
Initial results can be seen immediately after the first session. Full effects usually appear around two weeks after the second treatment. Results may vary depending on the individual.
How often should Prostrolane Inner B SE treatments be done?
We recommend two sessions spaced about two weeks apart for best and longer-lasting results. The ideal treatment schedule may vary depending on the individual and the severity of under-eye concerns.
Distribution is permissible solely upon presentation of a valid medical prescription. This directive does not pertain to individuals engaged in the field of healing or healthcare.
